These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27028939)

  • 1. Pregabalin prescriptions in the United Kingdom: a drug utilisation study of The Health Improvement Network (THIN) primary care database.
    Asomaning K; Abramsky S; Liu Q; Zhou X; Sobel RE; Watt S
    Int J Clin Pract; 2016 May; 70(5):380-8. PubMed ID: 27028939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregabalin is increasingly prescribed for neuropathic pain, generalised anxiety disorder and epilepsy but many patients discontinue treatment.
    Wettermark B; Brandt L; Kieler H; Bodén R
    Int J Clin Pract; 2014 Jan; 68(1):104-10. PubMed ID: 23815622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregabalin Prescription for Neuropathic Pain and Fibromyalgia: A Descriptive Study Using Administrative Database in Japan.
    Hirakata M; Yoshida S; Tanaka-Mizuno S; Kuwauchi A; Kawakami K
    Pain Res Manag; 2018; 2018():2786151. PubMed ID: 29973966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
    Gore M; Sadosky A; Tai KS; Stacey B
    Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
    Tassone DM; Boyce E; Guyer J; Nuzum D
    Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of pregabalin treatment in Taiwan: a nation-wide population-based study.
    Wang YF; Chen YT; Tsai CW; Yen YC; Chen YC; Shia BC; Wang SJ
    J Headache Pain; 2020 May; 21(1):54. PubMed ID: 32429883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacoeconomic outcomes for pregabalin: a systematic review in neuropathic pain, generalized anxiety disorder, and epilepsy from a Spanish perspective.
    Darbà J; Kaskens L; Pérez C; Álvarez E; Navarro-Artieda R; Sicras-Mainar A
    Adv Ther; 2014 Jan; 31(1):1-29. PubMed ID: 24390901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience from therapeutic drug monitoring and gender aspects of gabapentin and pregabalin in clinical practice.
    Johannessen Landmark C; Beiske G; Baftiu A; Burns ML; Johannessen SI
    Seizure; 2015 May; 28():88-91. PubMed ID: 25758302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in First Gabapentin and Pregabalin Prescriptions in Primary Care in the United Kingdom, 1993-2017.
    Montastruc F; Loo SY; Renoux C
    JAMA; 2018 Nov; 320(20):2149-2151. PubMed ID: 30480717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-a pharmacoepidemiological study and clinical implications.
    Baftiu A; Johannessen Landmark C; Rusten IR; Feet SA; Johannessen SI; Larsson PG
    Eur J Clin Pharmacol; 2016 Oct; 72(10):1245-1254. PubMed ID: 27411937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of pregabalin in patients with painful neuropathic disorders under the care of general practitioners in the U.K.
    Berger A; Sadosky A; Dukes E; Edelsberg J; Oster G
    Pain Pract; 2009; 9(1):18-34. PubMed ID: 19019054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of treatment for restless legs syndrome in primary care in the United Kingdom.
    Martinez C; Finnern HW; Rietbrock S; Eaton S; Chaudhuri KR; Schapira AH
    Clin Ther; 2008 Feb; 30(2):405-18. PubMed ID: 18343278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing the dosage of pregabalin in patients with focal epilepsy decreases the frequency of seizures and ameliorates symptoms of anxiety, depression and insomnia.
    Murawiec S; Chudek J; Nieves W; Almgren-Rachtan A; Jedrzejczak J
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13015-13024. PubMed ID: 33378053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration.
    Freynhagen R; Baron R; Kawaguchi Y; Malik RA; Martire DL; Parsons B; Rey RD; Schug SA; Jensen TS; Tölle TR; Ushida T; Whalen E
    Postgrad Med; 2021 Jan; 133(1):1-9. PubMed ID: 33423590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and resource utilization patterns in patients with refractory neuropathic pain prescribed pregabalin for the first time in routine medical practice in primary care settings in Spain.
    Pérez C; Navarro A; Saldaña MT; Masramón X; Pérez M; Rejas J
    Pain Med; 2013 Dec; 14(12):1954-63. PubMed ID: 24330229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and treatment of neuropathic pain: the UK primary care perspective.
    Hall GC; Carroll D; Parry D; McQuay HJ
    Pain; 2006 May; 122(1-2):156-62. PubMed ID: 16545908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consequences on economic outcomes of generic versus brand-name drugs used in routine clinical practice: the case of treating peripheral neuropathic pain or generalized anxiety disorder with pregabalin.
    Sicras-Mainar A; Rejas-Gutiérrez J; Pérez-Paramo M; Sánchez-Alvarez L; Navarro-Artieda R; Darbà J
    Expert Rev Pharmacoecon Outcomes Res; 2019 Feb; 19(1):45-57. PubMed ID: 30182806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Re: Pregabalin prescriptions in the United Kingdom - a drug utilisation study of The Health Improvement Network (THIN) primary care database by Asomaning et al.
    Pottegård A; Tjäderborn M; Schjerning O; Nielsen J; Damkier P; Bodén R
    Int J Clin Pract; 2016 Aug; 70(8):696. PubMed ID: 27466015
    [No Abstract]   [Full Text] [Related]  

  • 19. Prescribing practice of pregabalin/gabapentin in pain therapy: an evaluation of German claim data.
    Viniol A; Ploner T; Hickstein L; Haasenritter J; Klein KM; Walker J; Donner-Banzhoff N; Becker A
    BMJ Open; 2019 Mar; 9(3):e021535. PubMed ID: 30928920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine prescribing of gabapentin or pregabalin in supportive and palliative care: what are the comparative performances of the medications in a palliative care population?
    Clark K; Quinn SJ; Doogue M; Sanderson C; Lovell M; Currow DC
    Support Care Cancer; 2015 Sep; 23(9):2517-20. PubMed ID: 26162537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.